ClinicalTrials.Veeva
Menu

Find clinical trials for Alzheimer's Disease in Jacksonville, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Alzheimer Disease
Dementia
Cognitive Dysfunction
Mental Disorders
Brain Diseases
Psychomotor Agitation
Nervous System Diseases

Alzheimer's Disease trials near Jacksonville, FL, USA:

A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's...

Enrolling
Early Alzheimer's Disease
Drug: Placebo
Drug: CT1812

Phase 2

Cognition Therapeutics
Cognition Therapeutics

Jacksonville, Florida, United States and 29 other locations

This is a randomized, double-blind, sham-controlled, adaptive-design pivotal study of sensory stimulation in subjects with mild to moderate Alzheimer's...

Enrolling
Alzheimer Disease 6
Dementia of Alzheimer Type
Device: Sensory Stimulation System (GS120) - Sham
Device: Sensory Stimulation System (GS120) - Active
Cognito Therapeutics
Cognito Therapeutics

Orange Park, Florida, United States and 67 other locations

The reason for this study is to collect safety and efficacy information regarding the study drug remternetug in participants with early Alzheimer's...

Active, not recruiting
Alzheimer's Disease
Drug: Remternetug (SC)
Drug: Placebo

Phase 3

Lilly
Lilly

Jacksonville, Florida, United States and 75 other locations

is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Tri...

Enrolling
Preclinical Alzheimer's Disease
Early Preclinical Alzheimer's Disease
Drug: Lecanemab
Drug: Placebo

Phase 3

Eisai
Eisai

Jacksonville, Florida, United States and 117 other locations

Locations recently updated

The purpose of this study is to assess the effect of JNJ-64042056 on cognitive decline, as measured by Preclinical Alzheimer's disease...

Enrolling
Preclinical Alzheimer's Disease
Drug: JNJ-64042056
Drug: Placebo

Phase 2

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Jacksonville, Florida, United States and 50 other locations

to alleviate symptoms when given to people with mild to moderate Alzheimer Disease (AD) dementia. This is done by looking at partic...

Enrolling
Alzheimer Disease
Drug: Placebo
Drug: Mevidalen

Phase 2

Lilly
Lilly

Jacksonville, Florida, United States and 44 other locations

This is an open-label extension for a multicenter, randomized, double-blind, sham-controlled, adaptive design pivotal study.Participants who complete...

Invitation-only
Alzheimer Disease
Dementia of Alzheimer Type
Device: Sensory Stimulation System (GS120) - Active
Cognito Therapeutics
Cognito Therapeutics

Orange Park, Florida, United States and 52 other locations

frequency and severity of ARIA-E in adults with early symptomatic Alzheimer's disease (AD) and explore participant characteristics ...

Active, not recruiting
Alzheimer's Disease
Neurodegenerative Diseases
Drug: Placebo
Drug: Donanemab

Phase 3

Lilly
Lilly

Jacksonville, Florida, United States and 48 other locations

Locations recently updated

A 52-week safety and efficacy study of simufilam (PTI-125) given twice daily to participants with mild-to-moderate Alzheimer's disease...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: Simufilam

Phase 3

Cassava Sciences

Jacksonville, Florida, United States and 88 other locations

The primary purpose of this study is to evaluate the effect of JNJ-63733657 versus placebo on clinical decline as measured by the Integrated Alzheimer's...

Active, not recruiting
Alzheimer Disease
Cognitive Dysfunction
Drug: JNJ-63733657
Drug: Placebo

Phase 2

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Jacksonville, Florida, United States and 122 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems